File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma

TitleGenipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
Authors
Keywordschemotaxis
genipin
HCC
macrophage
postoperative recurrence
PPARγ
Issue Date16-Oct-2023
PublisherIvyspring International Publisher
Citation
International Journal of Biological Sciences, 2023, v. 19, n. 16, p. 5257-5274 How to Cite?
Abstract

A high postoperative tumour recurrence rate has significantly rendered a poorer prognosis in hepatocellular carcinoma (HCC) patients. The aim of this study is to identify a natural compound genipin as a potential and effective candidate to suppress the postoperative recurrence of HCC. Clinical analysis revealed that infiltration of macrophage into the adjacent tissue but not HCC predicted patients' poor prognosis on recurrence-free survival. Genipin intervention suppressed the Ly6C+CD11b+F4/80+ pro-inflammatory macrophage infiltration in the postoperative liver of mice. Adoptive transfer of pro-inflammatory monocytic cells completely abolished the inhibitory effect of genipin on HCC recurrence. Transcriptomic analysis on FACs-sorted macrophages from the postoperative livers of mice revealed that PPARγ signalling was involved in the regulatory effect of genipin. Genipin is directly bound to PPARγ, causing PPARγ-induced p65 degradation, which in turn suppressed the transcriptional activation of CCR2 signalling. PPARγ antagonist GW9662 abrogated the effects of genipin on CCR2-medaited macrophage infiltration as well as HCC recurrence. Cytokine array analysis identified that genipin intervention potently suppressed the secretion of CCL2 further partially contributed to the pro-inflammatory macrophage infiltration into the postoperative liver. Multiplex immunostaining on tissue array of human HCC revealed that PPARγ expression was inversely associated with CCL2 and the macrophage infiltration in the adjacent liver of HCC patients. Our works provide scientific evidence for the therapeutic potential of genipin as a PPARγ agonist in preventing postoperative recurrence of HCC.


Persistent Identifierhttp://hdl.handle.net/10722/340976
ISSN
2023 Impact Factor: 8.2
2023 SCImago Journal Rankings: 2.114
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWu, Junyu-
dc.contributor.authorChan, Yau-Tuen-
dc.contributor.authorLu, Yuanjun-
dc.contributor.authorFeng, Zixin-
dc.contributor.authorYuan, Hongchao-
dc.contributor.authorXu, Xiaoyu-
dc.contributor.authorXu, Lin-
dc.contributor.authorZhang, Cheng-
dc.contributor.authorFeng, Yibin-
dc.contributor.authorTan, Hor-Yue-
dc.contributor.authorWang, Ning-
dc.date.accessioned2024-03-11T10:48:45Z-
dc.date.available2024-03-11T10:48:45Z-
dc.date.issued2023-10-16-
dc.identifier.citationInternational Journal of Biological Sciences, 2023, v. 19, n. 16, p. 5257-5274-
dc.identifier.issn1449-2288-
dc.identifier.urihttp://hdl.handle.net/10722/340976-
dc.description.abstract<p>A high postoperative tumour recurrence rate has significantly rendered a poorer prognosis in hepatocellular carcinoma (HCC) patients. The aim of this study is to identify a natural compound genipin as a potential and effective candidate to suppress the postoperative recurrence of HCC. Clinical analysis revealed that infiltration of macrophage into the adjacent tissue but not HCC predicted patients' poor prognosis on recurrence-free survival. Genipin intervention suppressed the Ly6C+CD11b+F4/80+ pro-inflammatory macrophage infiltration in the postoperative liver of mice. Adoptive transfer of pro-inflammatory monocytic cells completely abolished the inhibitory effect of genipin on HCC recurrence. Transcriptomic analysis on FACs-sorted macrophages from the postoperative livers of mice revealed that PPARγ signalling was involved in the regulatory effect of genipin. Genipin is directly bound to PPARγ, causing PPARγ-induced p65 degradation, which in turn suppressed the transcriptional activation of CCR2 signalling. PPARγ antagonist GW9662 abrogated the effects of genipin on CCR2-medaited macrophage infiltration as well as HCC recurrence. Cytokine array analysis identified that genipin intervention potently suppressed the secretion of CCL2 further partially contributed to the pro-inflammatory macrophage infiltration into the postoperative liver. Multiplex immunostaining on tissue array of human HCC revealed that PPARγ expression was inversely associated with CCL2 and the macrophage infiltration in the adjacent liver of HCC patients. Our works provide scientific evidence for the therapeutic potential of genipin as a PPARγ agonist in preventing postoperative recurrence of HCC.<br></p>-
dc.languageeng-
dc.publisherIvyspring International Publisher-
dc.relation.ispartofInternational Journal of Biological Sciences-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectchemotaxis-
dc.subjectgenipin-
dc.subjectHCC-
dc.subjectmacrophage-
dc.subjectpostoperative recurrence-
dc.subjectPPARγ-
dc.titleGenipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.7150/ijbs.87327-
dc.identifier.scopuseid_2-s2.0-85175086670-
dc.identifier.volume19-
dc.identifier.issue16-
dc.identifier.spage5257-
dc.identifier.epage5274-
dc.identifier.eissn1449-2288-
dc.identifier.isiWOS:001089330300005-
dc.identifier.issnl1449-2288-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats